News Summary: Pfizer drug gets breakthrough label

Published



DRUG DESIGNATION: Pfizer says U.S. regulators have classified its experimental pill for advanced, often-deadly breast cancer as a breakthrough therapy. That’s done to speed up development and review of treatments seen as big advances.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.